Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06311188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date pushed from Sep 18, 2026 to Oct 5, 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 8 of 8 entries
    • Study description expanded, about 5 words
  2. Start date: Jul 8, 2026 to Sep 18, 2026v16
  3. Start date: Apr 8, 2026 to Jul 8, 2026v15
  4. Primary completion date: Jan 30, 2026 to Jan 30, 2027
    • Start date: Jan 8, 2026 to Apr 8, 2026
    • Study completion date: Jan 31, 2026 to Jan 31, 2027
    v14
  5. Primary completion date: Jan 26, 2026 to Jan 30, 2026
    • Start date: Dec 30, 2025 to Jan 8, 2026
    v13
Show 11 earlier versionsHide 11 earlier versions
  1. Primary completion date: Jan 20, 2026 to Jan 26, 2026
    • Start date: Dec 21, 2025 to Dec 30, 2025
    v12
  2. Start date: Sep 21, 2025 to Dec 21, 2025
    • Primary completion date: Dec 20, 2025 to Jan 20, 2026
    v11
  3. Start date: Jul 21, 2025 to Sep 21, 2025v10
  4. Start date: May 16, 2025 to Jul 21, 2025v9
  5. Start date: Feb 16, 2025 to May 16, 2025v8
  6. Primary completion date: Jan 5, 2025 to Dec 20, 2025
    • Start date: Dec 16, 2024 to Feb 16, 2025
    • Study completion date: Jan 31, 2025 to Jan 31, 2026
    v7
  7. Start date: Oct 15, 2024 to Dec 16, 2024
    • Primary completion date: Aug 30, 2025 to Jan 5, 2025
    • Study completion date: Jan 31, 2026 to Jan 31, 2025
    v6
  8. Primary completion date: Nov 30, 2024 to Aug 30, 2025
    • Start date: Jun 30, 2024 to Oct 15, 2024
    • Study completion date: Jan 31, 2025 to Jan 31, 2026
    v5
  9. Start date: Apr 14, 2024 to Jun 30, 2024v4
  10. Start date: Mar 14, 2024 to Apr 14, 2024
    • Study title expanded, about 5 words
    v3
  11. Primary endpoints: 1 to 2
    • Eligibility criteria expanded, about 36 words
    • Secondary endpoints: 9 to 8
    • Study description expanded, about 4 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Michigan
373 trials monitored
See 23 trials at risk
PTSD
889 trials monitored
See 54 trials at risk
The purpose of this study is to investigate justice-involved Black/African American female adolescents' (JI BAFAs; N=35) self-reported outcomes: stress, posttraumatic stress disorder (PTSD), recidivism, etc., as well as their parents/caregivers' (P/Cs; N=35) stress and pre- and post- intervention results along with their views of an adapted intervention.
Trial Details
NCT Number NCT06311188
Lead Sponsor University of Michigan
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions
(from sponsor)		 Stress, Trauma, PTSD, HPA
Related terms Stress Disorders, Post-Traumatic, Wounds and Injuries
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov